PharVision Advisers’s Backblaze BLZE Stock Holding History

PharVision Advisers’s Portfolio BLZE Stock Details BLZE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-36,502	Closed	-$170K	–	163
2025 Q4	$170K	Buy	+36,502	New	+$250K	0.09%	596

Other funds holding BLZE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

PLC

Pillsbury Lake Capital San Francisco, California $221M AUM

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

WCA

Whetstone Capital Advisors Shawnee Mission, Kansas $288M AUM 44.06% 1-Year Est. Return

AIC

AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return

PharVision Advisers's BLZE Position: Q1 2026 in Review

PharVision Advisers sold out of Backblaze (BLZE) in Q1 2026, closing a stake of 36,502 shares — an estimated $170K sold.

PharVision Advisers first reported a position in BLZE in Q4 2025 and held it in 1 quarter. The position peaked at $170K in Q4 2025. 138 funds tracked by Wall St. Rank hold BLZE as of Q1 2026.

PharVision Advisers reported no remaining Backblaze position as of Q1 2026 after selling out during the quarter.
PharVision Advisers sold 36,502 Backblaze shares in Q1 2026, an estimated $170K.
PharVision Advisers first reported a position in Backblaze in Q4 2025 and held it in 1 quarter.
PharVision Advisers's Backblaze position peaked at $170K in Q4 2025.
138 funds tracked by Wall St. Rank held Backblaze as of Q1 2026.

Based on PharVision Advisers's 13F filing for Q1 2026, filed 22 Apr 2026.